Verrica Pharmaceuticals Inc. cotiza a 4.01 USD y tiene una capitalización bursátil de $69M. En los últimos 12 meses ha facturado $30M con un margen de flujo de caja libre del -49.5%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for th…
| Periodo | 2026-11 | 2026-08 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | — | $-0.48 | $-0.51 | $-0.03 |
| Estimado | $-0.52 | $-0.47 | $-0.64 | $-0.06 |
| Sorpresa | — | -2.1% | +20.3% | +50.0% |
| Métrica | VRCA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -34.3% | -38.6% | +4.4% |
| Net Margin | -50.3% | -33.6% | -16.7% |
| FCF Margin | -49.5% | -13.9% | -35.7% |
| ROE | -72.3% | -40.4% | -31.9% |
| ROA | -38.0% | -32.0% | -5.9% |
| Current Ratio | 2.59 | 2.84 | -0.25 |
| Debt / Equity | 0.00 | 0.28 | -0.28 |